Diclofenac ophthalmic - Escalon/West Pharmaceutical Services

Drug Profile

Diclofenac ophthalmic - Escalon/West Pharmaceutical Services

Alternative Names: Diclofenac - Ocufit SR; Ocufit SR - diclofenac

Latest Information Update: 25 Jun 2001

Price : $50

At a glance

  • Originator Escalon Medical; West Pharmaceutical Services
  • Class Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
  • Mechanism of Action Arachidonic acid inhibitors; Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Ocular inflammation

Most Recent Events

  • 25 Jun 2001 Discontinued-Preclinical for Ocular inflammation in USA (Ophthalmic)
  • 26 Jan 1999 New profile
  • 26 Jan 1999 Preclinical development for Ocular inflammation in USA (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top